MEDTRONIC PLC (2M6.DE) Stock Fundamental Analysis
Europe - Frankfurt Stock Exchange - FRA:2M6 - IE00BTN1Y115 - Common Stock
91.27 EUR
+0.77 (+0.85%)
Taking everything into account, 2M6 scores 5 out of 10 in our fundamental rating. 2M6 was compared to 63 industry peers in the Health Care Equipment & Supplies industry. Both the profitability and the financial health of 2M6 get a neutral evaluation. Nothing too spectacular is happening here. 2M6 is not valued too expensively and it also shows a decent growth rate.
1. Profitability
1.1 Basic Checks
In the past year 2M6 was profitable.
2M6 had a positive operating cash flow in the past year.
In the past 5 years 2M6 has always been profitable.
In the past 5 years 2M6 always reported a positive cash flow from operatings.
1.2 Ratios
2M6 has a Return On Assets of 5.12%. This is in the better half of the industry: 2M6 outperforms 66.67% of its industry peers.
Looking at the Return On Equity, with a value of 9.73%, 2M6 is in the better half of the industry, outperforming 65.08% of the companies in the same industry.
2M6 has a Return On Invested Capital (6.74%) which is comparable to the rest of the industry.
The Average Return On Invested Capital over the past 3 years for 2M6 is below the industry average of 9.33%.
The 3 year average ROIC (6.35%) for 2M6 is below the current ROIC(6.74%), indicating increased profibility in the last year.
| Industry Rank | Sector Rank | ||
|---|---|---|---|
| ROA | 5.12% | ||
| ROE | 9.73% | ||
| ROIC | 6.74% |
ROA(3y)4.43%
ROA(5y)4.54%
ROE(3y)8.11%
ROE(5y)8.19%
ROIC(3y)6.35%
ROIC(5y)6.24%
1.3 Margins
With a decent Profit Margin value of 13.63%, 2M6 is doing good in the industry, outperforming 79.37% of the companies in the same industry.
2M6's Profit Margin has declined in the last couple of years.
2M6 has a Operating Margin of 19.57%. This is amongst the best in the industry. 2M6 outperforms 85.71% of its industry peers.
In the last couple of years the Operating Margin of 2M6 has remained more or less at the same level.
2M6 has a better Gross Margin (65.38%) than 68.25% of its industry peers.
2M6's Gross Margin has been stable in the last couple of years.
| Industry Rank | Sector Rank | ||
|---|---|---|---|
| OM | 19.57% | ||
| PM (TTM) | 13.63% | ||
| GM | 65.38% |
OM growth 3Y-3.47%
OM growth 5Y0.37%
PM growth 3Y-4.39%
PM growth 5Y-3.44%
GM growth 3Y-1.55%
GM growth 5Y-0.76%
2. Health
2.1 Basic Checks
The Return on Invested Capital (ROIC) is just above the Cost of Capital (WACC), so 2M6 is still creating some value.
The number of shares outstanding for 2M6 has been reduced compared to 1 year ago.
The number of shares outstanding for 2M6 has been reduced compared to 5 years ago.
Compared to 1 year ago, 2M6 has a worse debt to assets ratio.
2.2 Solvency
An Altman-Z score of 3.15 indicates that 2M6 is not in any danger for bankruptcy at the moment.
2M6 has a better Altman-Z score (3.15) than 63.49% of its industry peers.
The Debt to FCF ratio of 2M6 is 5.39, which is a neutral value as it means it would take 2M6, 5.39 years of fcf income to pay off all of its debts.
2M6's Debt to FCF ratio of 5.39 is in line compared to the rest of the industry. 2M6 outperforms 57.14% of its industry peers.
A Debt/Equity ratio of 0.55 indicates that 2M6 is somewhat dependend on debt financing.
2M6 has a Debt to Equity ratio of 0.55. This is in the lower half of the industry: 2M6 underperforms 63.49% of its industry peers.
| Industry Rank | Sector Rank | ||
|---|---|---|---|
| Debt/Equity | 0.55 | ||
| Debt/FCF | 5.39 | ||
| Altman-Z | 3.15 |
ROIC/WACC1.01
WACC6.68%
2.3 Liquidity
2M6 has a Current Ratio of 2.01. This indicates that 2M6 is financially healthy and has no problem in meeting its short term obligations.
2M6 has a Current ratio of 2.01. This is in the better half of the industry: 2M6 outperforms 60.32% of its industry peers.
A Quick Ratio of 1.50 indicates that 2M6 should not have too much problems paying its short term obligations.
2M6 has a better Quick ratio (1.50) than 68.25% of its industry peers.
| Industry Rank | Sector Rank | ||
|---|---|---|---|
| Current Ratio | 2.01 | ||
| Quick Ratio | 1.5 |
3. Growth
3.1 Past
The Earnings Per Share has been growing slightly by 7.24% over the past year.
2M6 shows a small growth in Earnings Per Share. Measured over the last years, the EPS has been growing by 3.68% yearly.
The Revenue has been growing slightly by 5.34% in the past year.
Measured over the past years, 2M6 shows a small growth in Revenue. The Revenue has been growing by 3.01% on average per year.
EPS 1Y (TTM)7.24%
EPS 3Y-0.72%
EPS 5Y3.68%
EPS Q2Q%7.94%
Revenue 1Y (TTM)5.34%
Revenue growth 3Y1.91%
Revenue growth 5Y3.01%
Sales Q2Q%6.64%
3.2 Future
2M6 is expected to show a small growth in Earnings Per Share. In the coming years, the EPS will grow by 6.57% yearly.
The Revenue is expected to grow by 5.37% on average over the next years.
EPS Next Y3.31%
EPS Next 2Y5.62%
EPS Next 3Y6.07%
EPS Next 5Y6.57%
Revenue Next Year7.02%
Revenue Next 2Y6.24%
Revenue Next 3Y5.7%
Revenue Next 5Y5.37%
3.3 Evolution
The EPS growth rate is accelerating: in the next years the growth will be better than in the last years.
The Revenue growth rate is accelerating: in the next years the growth will be better than in the last years.
4. Valuation
4.1 Price/Earnings Ratio
A Price/Earnings ratio of 18.78 indicates a rather expensive valuation of 2M6.
Compared to the rest of the industry, the Price/Earnings ratio of 2M6 indicates a rather cheap valuation: 2M6 is cheaper than 80.95% of the companies listed in the same industry.
2M6's Price/Earnings ratio indicates a valuation a bit cheaper than the S&P500 average which is at 26.15.
With a Price/Forward Earnings ratio of 17.22, 2M6 is valued on the expensive side.
66.67% of the companies in the same industry are more expensive than 2M6, based on the Price/Forward Earnings ratio.
2M6's Price/Forward Earnings ratio indicates a rather cheap valuation when compared to the S&P500 average which is at 36.12.
| Industry Rank | Sector Rank | ||
|---|---|---|---|
| PE | 18.78 | ||
| Fwd PE | 17.22 |
4.2 Price Multiples
Compared to the rest of the industry, the Enterprise Value to EBITDA ratio of 2M6 indicates a somewhat cheap valuation: 2M6 is cheaper than 61.90% of the companies listed in the same industry.
Based on the Price/Free Cash Flow ratio, 2M6 is valued a bit cheaper than 71.43% of the companies in the same industry.
| Industry Rank | Sector Rank | ||
|---|---|---|---|
| P/FCF | 25.56 | ||
| EV/EBITDA | 15.47 |
4.3 Compensation for Growth
The high PEG Ratio(NY), which compensates the Price/Earnings for growth, indicates an expensive valuation of the company.
The decent profitability rating of 2M6 may justify a higher PE ratio.
PEG (NY)5.67
PEG (5Y)5.1
EPS Next 2Y5.62%
EPS Next 3Y6.07%
5. Dividend
5.1 Amount
2M6 has a Yearly Dividend Yield of 2.86%. Purely for dividend investing, there may be better candidates out there.
Compared to an average industry Dividend Yield of 2.22, 2M6 pays a better dividend. On top of this 2M6 pays more dividend than 87.30% of the companies listed in the same industry.
2M6's Dividend Yield is comparable with the S&P500 average which is at 2.41.
| Industry Rank | Sector Rank | ||
|---|---|---|---|
| Dividend Yield | 2.86% |
5.2 History
The dividend of 2M6 has a limited annual growth rate of 5.10%.
Dividend Growth(5Y)5.1%
Div Incr Years7
Div Non Decr Years7
5.3 Sustainability
2M6 pays out 77.27% of its income as dividend. This is not a sustainable payout ratio.
The dividend of 2M6 is growing, but earnings are growing more, so the dividend growth is sustainable.
DP77.27%
EPS Next 2Y5.62%
EPS Next 3Y6.07%
FRA:2M6 (11/26/2025, 7:00:00 PM)
91.27
+0.77 (+0.85%)
Chartmill FA Rating
GICS SectorHealth Care
GICS IndustryGroupHealth Care Equipment & Services
GICS IndustryHealth Care Equipment & Supplies
Earnings (Last)
Earnings (Next)
Inst Owners87.1%
Inst Owner ChangeN/A
Ins Owners0.29%
Ins Owner ChangeN/A
Market Cap117.07B
Revenue(TTM)34.76B
Net Income(TTM)4.66B
Analysts72.82
Price Target88.56 (-2.97%)
Short Float %N/A
Short RatioN/A
Dividend
| Industry Rank | Sector Rank | ||
|---|---|---|---|
| Dividend Yield | 2.86% |
Yearly Dividend2.4
Dividend Growth(5Y)5.1%
DP77.27%
Div Incr Years7
Div Non Decr Years7
Ex-DateN/A
Surprises & Revisions
EPS beat(2)2
Avg EPS beat(2)1.54%
Min EPS beat(2)1.49%
Max EPS beat(2)1.59%
EPS beat(4)3
Avg EPS beat(4)1.05%
Min EPS beat(4)-0.08%
Max EPS beat(4)1.59%
EPS beat(8)6
Avg EPS beat(8)1.56%
EPS beat(12)9
Avg EPS beat(12)1.82%
EPS beat(16)10
Avg EPS beat(16)1.17%
Revenue beat(2)2
Avg Revenue beat(2)0.54%
Min Revenue beat(2)0.17%
Max Revenue beat(2)0.91%
Revenue beat(4)3
Avg Revenue beat(4)0.07%
Min Revenue beat(4)-1.38%
Max Revenue beat(4)0.91%
Revenue beat(8)6
Avg Revenue beat(8)0.26%
Revenue beat(12)9
Avg Revenue beat(12)0.38%
Revenue beat(16)10
Avg Revenue beat(16)-0.26%
PT rev (1m)2.93%
PT rev (3m)2.37%
EPS NQ rev (1m)0%
EPS NQ rev (3m)-0.71%
EPS NY rev (1m)0%
EPS NY rev (3m)0.22%
Revenue NQ rev (1m)0%
Revenue NQ rev (3m)1.43%
Revenue NY rev (1m)0%
Revenue NY rev (3m)0.37%
Valuation
| Industry Rank | Sector Rank | ||
|---|---|---|---|
| PE | 18.78 | ||
| Fwd PE | 17.22 | ||
| P/S | 3.96 | ||
| P/FCF | 25.56 | ||
| P/OCF | 18.97 | ||
| P/B | 2.83 | ||
| P/tB | N/A | ||
| EV/EBITDA | 15.47 |
EPS(TTM)4.86
EY5.32%
EPS(NY)5.3
Fwd EY5.81%
FCF(TTM)3.57
FCFY3.91%
OCF(TTM)4.81
OCFY5.27%
SpS23.03
BVpS32.25
TBVpS-3.59
PEG (NY)5.67
PEG (5Y)5.1
Graham Number59.39
Profitability
| Industry Rank | Sector Rank | ||
|---|---|---|---|
| ROA | 5.12% | ||
| ROE | 9.73% | ||
| ROCE | 8.43% | ||
| ROIC | 6.74% | ||
| ROICexc | 7.5% | ||
| ROICexgc | 29.59% | ||
| OM | 19.57% | ||
| PM (TTM) | 13.63% | ||
| GM | 65.38% | ||
| FCFM | 15.51% |
ROA(3y)4.43%
ROA(5y)4.54%
ROE(3y)8.11%
ROE(5y)8.19%
ROIC(3y)6.35%
ROIC(5y)6.24%
ROICexc(3y)7.09%
ROICexc(5y)7.05%
ROICexgc(3y)29.85%
ROICexgc(5y)33.32%
ROCE(3y)7.94%
ROCE(5y)7.8%
ROICexgc growth 3Y-11.61%
ROICexgc growth 5Y-5.52%
ROICexc growth 3Y-2.49%
ROICexc growth 5Y3.26%
OM growth 3Y-3.47%
OM growth 5Y0.37%
PM growth 3Y-4.39%
PM growth 5Y-3.44%
GM growth 3Y-1.55%
GM growth 5Y-0.76%
F-Score7
Asset Turnover0.38
Health
| Industry Rank | Sector Rank | ||
|---|---|---|---|
| Debt/Equity | 0.55 | ||
| Debt/FCF | 5.39 | ||
| Debt/EBITDA | 2.72 | ||
| Cap/Depr | 62.54% | ||
| Cap/Sales | 5.39% | ||
| Interest Coverage | 9.24 | ||
| Cash Conversion | 74.13% | ||
| Profit Quality | 113.8% | ||
| Current Ratio | 2.01 | ||
| Quick Ratio | 1.5 | ||
| Altman-Z | 3.15 |
F-Score7
WACC6.68%
ROIC/WACC1.01
Cap/Depr(3y)59.68%
Cap/Depr(5y)55.94%
Cap/Sales(3y)5.04%
Cap/Sales(5y)4.79%
Profit Quality(3y)124.85%
Profit Quality(5y)125.74%
High Growth Momentum
Growth
EPS 1Y (TTM)7.24%
EPS 3Y-0.72%
EPS 5Y3.68%
EPS Q2Q%7.94%
EPS Next Y3.31%
EPS Next 2Y5.62%
EPS Next 3Y6.07%
EPS Next 5Y6.57%
Revenue 1Y (TTM)5.34%
Revenue growth 3Y1.91%
Revenue growth 5Y3.01%
Sales Q2Q%6.64%
Revenue Next Year7.02%
Revenue Next 2Y6.24%
Revenue Next 3Y5.7%
Revenue Next 5Y5.37%
EBIT growth 1Y8.97%
EBIT growth 3Y-1.62%
EBIT growth 5Y3.4%
EBIT Next Year19.44%
EBIT Next 3Y10.5%
EBIT Next 5Y9.23%
FCF growth 1Y19.33%
FCF growth 3Y-4.64%
FCF growth 5Y-2.95%
OCF growth 1Y22.55%
OCF growth 3Y-1.39%
OCF growth 5Y-0.53%
MEDTRONIC PLC / 2M6.DE FAQ
What is the ChartMill fundamental rating of MEDTRONIC PLC (2M6.DE) stock?
ChartMill assigns a fundamental rating of 5 / 10 to 2M6.DE.
What is the valuation status of MEDTRONIC PLC (2M6.DE) stock?
ChartMill assigns a valuation rating of 5 / 10 to MEDTRONIC PLC (2M6.DE). This can be considered as Fairly Valued.
How profitable is MEDTRONIC PLC (2M6.DE) stock?
MEDTRONIC PLC (2M6.DE) has a profitability rating of 6 / 10.
What are the PE and PB ratios of MEDTRONIC PLC (2M6.DE) stock?
The Price/Earnings (PE) ratio for MEDTRONIC PLC (2M6.DE) is 18.78 and the Price/Book (PB) ratio is 2.83.
How financially healthy is MEDTRONIC PLC?
The financial health rating of MEDTRONIC PLC (2M6.DE) is 6 / 10.